10 Best Healthcare Equipment Stocks To Invest In 2014

Take a look around the pharmaceutical industry and you won't find many companies with market caps exceeding $100 billion (seven by my count). If you discount non-pharmaceutical businesses at Roche and Johnson & Johnson (NYSE: JNJ  ) , then the largest pure-play pharma company in the world is Pfizer (NYSE: PFE  ) . The giant weighs in at more than $200 billion -- nearly $30 billion larger than its next closest competitor -- and has been a stalwart of the industry for many decades. �

Established pharmaceutical companies can be great core holdings for your portfolio; what they lack in growth they can make up for in hefty dividends. They don't offer risk-free investments, but their larger pipelines can often swallow late-stage failures. Still, investors may be left wondering if bigger really is better, especially after Pfizer trimmed its 2013 guidance. Let's take a quick look at several opportunities and risks facing Pfizer to see if the biggest pharma company in the world is the best investment.

Hot Canadian Stocks To Own Right Now: Midway Gold Corporation(MDW)

Midway Gold Corp., an exploration stage company, engages in the acquisition, exploration, and development of mineral properties in North America. Its principal properties include the Spring Valley, Midway, Pan, and Gold Rock gold and silver mineral properties located in Nevada; and the Golden Eagle gold mineral property located in Washington. The company was formerly known as Red Emerald Resource Corp. and changed its name to Midway Gold Corp. in July 2002. Midway Gold Corp. was founded in 1996 and is headquartered in Englewood, Colorado.

Advisors' Opinion:

• [By Lisa Levin]

  Midway Gold (NYSE: MDW) shares fell 3.90% to reach a new 52-week low of $0.74. Midway Gold's trailing-twelve-month ROA is -11.16%.

  Posted-In: 52-Week LowsNews Movers & Shakers Intraday Update Markets

10 Best Healthcare Equipment Stocks To Invest In 2014: BG Medicine Inc.(BGMD)

BG Medicine, Inc., a life sciences company, engages in the discovery, development, and commercialization of diagnostic tests based on biomarkers in the United States. Its product pipeline includes BGM Galectin-3, a diagnostic test for heart failure that measures galectin-3 levels in blood plasma or serum; AMIPredict, a multivariate biomarker blood-based test for atherothrombotic cardiovascular disease; and LipidDx, a blood-based protein assay for the management of patients with lipid disorders. The company also offers TNF alpha blockers comprising Enbrel, Remicade and Humira, which are treatments indicated for autoimmune diseases, such as rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and Crohn?s disease. It has strategic collaborations and initiatives with pharmaceutical companies and other healthcare organizations, including Abbott Laboratories; ACS Biomarker B.V.; Humana Inc.; Merck & Co., Inc.; and Laboratory Corporation of America. The company was formerly known as Beyond Genomics, Inc. and changed its name to BG Medicine, Inc. in October 2004. BG Medicine, Inc. was founded in 2000 and is headquartered in Waltham, Massachusetts.

Advisors' Opinion:

• [By Roberto Pedone]

  Another stock that's starting to move within range of triggering a big breakout trade is BG Medicine (BGMD), which develops and commercializes novel cardiovascular diagnostic tests to address unmet medical needs in the U.S. This stock has been pushed lower by the sellers over the last three months, with shares down sharply by 20%.

  If you take a glance at the chart for BG Medicine, you'll notice that this stock has been uptrending a bit for the last month, with shares moving higher from its low of 90 cents per share to its recent high of $1.12 a share. During that uptrend, shares of BGMD have been making mostly higher lows and higher highs, which is bullish technical price action. That move has now pushed shares of BGMD within range of triggering a big breakout trade above some key near-term overhead resistance levels.

  Traders should now look for long-biased trades in BGMD if it manages to break out above some near-term overhead resistance levels at $1.08 to $1.12 a share with high volume. Look for a sustained move or close above those levels with volume that hits near or above its three-month average action of 1.56 million shares. If that breakout gets started soon, then BGMD will set up to re-fill some of its previous gap-down-day zone from May that started near $1.30 a share. Any high-volume move above $1.30 will then give BGMD a chance to tag its next major overhead resistance levels at $1.50 to around $1.70 a share.

  Traders can look to buy BGMD off weakness to anticipate that breakout and simply use a stop that sits right below some key near-term support levels at 96 cents to 90 cents per share. One can also buy BGMD off strength once it starts to clear those breakout levels with volume and then simply use a stop that sits a comfortable percentage from your entry point.

• [By James E. Brumley]

  What do BG Medicine, Inc. (NASDAQ:BGMD) and Pentair, Ltd. (NYSE:PNR) have in common? Most investors would say absolutely nothing. BGMD is a small cap medical diagnostics company, while PNR is a large cap industrial equipment manufacturer. Those are worlds that simply never collide. The directions each stock has been traveling in over the past few months have even been polar opposites.

10 Best Healthcare Equipment Stocks To Invest In 2014: Proofpoint Inc (PFPT)

Proofpoint, Inc. (Proofpoint), incorporated in 2002, is a security-as-a-service vendor that delivers data protection solutions, which helps medium- and large-sized organizations worldwide. Proofpoint�� security-as-a-service platform consists of an integrated suite of on-demand data protection solutions, including threat protection, regulatory compliance, archiving and governance, and secures communication. It provides a multi-tiered security-as-a-service platform consisting of solutions, platform technologies and infrastructure. The Company�� security-as-a-service platform includes four solutions bundled for the convenience of its customers: Proofpoint Enterprise Protection, Proofpoint Enterprise Privacy, Proofpoint Enterprise Archive and Proofpoint Enterprise Governance. Its platform services consist of content inspection, reputation, encryption and key management, notification and workflow, and analytics and search. During the year ended December 31, 2011, the Company acquired NextPage, Inc. In September 2013, Proofpoint Inc completed its acquisition of Armorize Technologies Inc. In October 2013, the Company acquired Silicon Valley based Sendmail, Inc.

The Company�� solutions are used by approximately 2,400 customers worldwide, including 26 of the Fortune 100, protecting tens of millions of end-users. It markets and sells its solutions worldwide both directly through the sales teams and indirectly through a hybrid model. It also distributes its solutions through International Business Machines Corp. (IBM), Microsoft Corporation and VMware, Inc.

Proofpoint Enterprise Protection

Proofpoint Enterprise Protection is the Company�� communications and collaboration security suite designed to protect customers' mission-critical messaging infrastructure from outside threats including spam, phishing, unpredictable e-mail volumes, malware and other forms of objectionable or dangerous content before they reach the enterprise. Key capabilities within proofpoint en! terprise protection include threat detection, virus protection, zero-hour threat detection and smart search.

Proofpoint Enterprise Privacy

The Company�� data loss prevention, encryption and compliance solution defends against leaks of confidential information, and helps ensure compliance with common United States, international and industry-specific data protection regulations, including HIPAA, GLBA, PIPEDA and PCI-DSS. Key capabilities within Proofpoint Enterprise Privacy include Advanced data loss prevention, Flexible remediation and supervision, Policy-based encryption and Secure file transfer.

Proofpoint Enterprise Archive

Proofpoint Enterprise Archive is designed to ensure accurate enforcement of data governance, data retention and supervision policies and mandates; cost effective litigation support through discovery, and active legal hold management. Proofpoint Enterprise Archive can store, govern and discover a range of data, including e-mail, instant message conversations, social media interactions, and other files throughout the enterprise. The key capabilities within Proofpoint Enterprise Archive include Secure cloud storage, Search performance, Flexible policy enforcement, Active legal-hold management and End-user supervision.

Proofpoint Enterprise Governance

Proofpoint Enterprise Governance provides organizations the ability to track, classify, monitor, and apply governance policies to unstructured information across the enterprise. The key capabilities within Proofpoint Enterprise Governance include Document Tracking-Digital Thread, Cloud-based Search and Analytics, and Flexible policy enforcement.

The Company competes with Cisco Systems, Inc., EMC Corporation, Google Inc., Hewlett-Packard Company, Intel and Microsoft.

Advisors' Opinion:

• [By Sean Williams]

  One company in particular I'd suggest putting back on the sales rack is Proofpoint (NASDAQ: PFPT  ) , a threat and regulatory security-as-a-service provider. The profit potential is certainly there. Proofpoint's SaaS model is built around getting the client hooked on its products and making it inconvenient and cost-inefficient for them to switch to a competitor. In other words, it's setting up its own razor-and-blades model that should fuel recurring revenue for years to come.

• [By John Kell]

  Security services provider Proofpoint Inc.(PFPT) shares popped after the company posted better-than-expected fourth-quarter results and issued optimistic revenue guidance. Shares jumped 10% to $40.24 premarket.

10 Best Healthcare Equipment Stocks To Invest In 2014: Owens Corning Inc(OC)

Owens Corning engages in the provision of composite and building materials systems worldwide. It operates in two segments, Composites and Building Materials. The Composites segment manufactures, fabricates, and sells glass reinforcements in the form of fiber; and manufactures and sells glass fiber products in the form of fabrics, mat, veil, and other specialized products. Its products are used in pipe, roofing shingles, sporting goods, computers, telecommunications cables, boats, aircraft, defense, automotive, industrial containers, and wind-energy applications in the power and energy, housing, water distribution, industrial, transportation, consumer, and aerospace/military markets. This segment sells its products directly to parts molders and fabricators; and glass fiber and/or glass mat directly to shingle manufacturers. The Building Materials segment manufactures and sells fiberglass insulation into residential, commercial, industrial, and other markets for thermal and acoustical applications. It also offers glass fiber pipe insulation, and energy flexible duct media and foam insulation products, such as thermal and acoustical batts, loose fill insulation, foam sheathing, and accessories for use in home construction and remodeling; and manufactures residential roofing shingles and oxidized asphalt materials used in residential and commercial construction and specialty applications. This segment sells its insulation products, and shingles and roofing accessories to insulation installers, home centers, lumberyards, retailers, distributors, and contractors; and asphalt to roofing contractors and distributors for built-up roofing asphalt systems, as well as to manufacturers in the automotive, chemical, rubber, and construction industries. Owens Corning was founded in 1938 and is headquartered in Toledo, Ohio.

Advisors' Opinion:

• [By Monica Gerson]

  Analysts at Bank of America downgraded Owens Corning (NYSE: OC) from ��uy��to ��eutral.��The target price for Owens Corning has been lowered from $43 to $40.

• [By Monica Gerson]

  Owens Corning (NYSE: OC) is projected to report its Q3 earnings at $0.65 per share on revenue of $1.39 billion.

  E*TRADE Financial (NASDAQ: ETFC) is expected to post its Q3 earnings at $0.17 per share on revenue of $419.41 million.

• [By Nicole Seghetti]

  Let's take a closer look at three stocks Fisher recently bought, including drugmaker Gilead Sciences (NASDAQ: GILD  ) , materials manufacturer Owens Corning (NYSE: OC  ) , and financial services provider CapitalSource (NYSE: CSE  ) .

10 Best Healthcare Equipment Stocks To Invest In 2014: AcelRx Pharmaceuticals Inc.(ACRX)

AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of acute and breakthrough pain in the United States. The company develops ARX-01, a Sufentanil NanoTab PCA system, which completed Phase II clinical trial for acute post-operative pain. The Sufentanil NanoTab PCA system consists of sufentanil, a high therapeutic index opioid; NanoTabs, a non-invasive sublingual dosage form; and a handheld PCA device that enables simple patient-controlled delivery of NanoTabs in the hospital setting and eliminates the risk of programming errors. Its products also include ARX-02, a Sufentanil NanoTab BTP Management System that completed Phase II clinical trial for the treatment of cancer breakthrough pain; and ARX-03, a Sufentanil/Triazolam NanoTab, which completed Phase II clinical trial to provide mild sedation, anxiety reduction, and pain relief for patients undergoing painful procedures in a ph ysician?s office. The company was formerly known as SuRx, Inc. and changed its name to AcelRx Pharmaceuticals, Inc. in August 2006. AcelRx Pharmaceuticals, Inc. was founded in 2005 and is headquartered in Redwood, California.

Advisors' Opinion:

• [By Roberto Pedone]

  One stock that's starting to trend within range of triggering a major breakout trade is AcelRx Pharmaceuticals (ACRX), a specialty pharmaceutical company involved in the development and commercialization of therapies for the treatment of acute and breakthrough pain. This stock is off to a booming start for the bulls so far in 2013, with shares up a whopping 189%.

  If you take a look at the chart for AcelRx Pharmaceuticals, you'll notice that this stock recently formed a double-bottom chart pattern at $11.46 to $11.43 a share. Following that bottom, shares of ACRX have now started to spike higher and move within range of taking out some key near-term overhead resistance levels. If those levels get taken out with volume soon, then ACRX will trigger a major breakout trade.

  Traders should now look for long-biased trades in ACRX if it manages to break out above some near-term overhead resistance levels at $12.57 to its 52-week high at $13.50 a share with high volume. Look for a sustained move or close above those levels with volume that hits near or above its three-month average volume of 648,667 shares. If that breakout triggers soon, then ACRX will set up to enter new 52-week-high territory above $13.50, which is bullish technical price action. Some possible upside targets off that breakout are $17 to $20 a share.

  Traders can look to buy ACRX off any weakness to anticipate that breakout and simply use a stop that sits right below $11.43 a share, or near its 50-day at $10.27 a share. One could also buy ACRX off strength once it takes out those breakout levels with volume and then simply use a stop that sits a comfortable percentage from your entry point.

  This stock is a favorite target of the bears, since the current short interest as a percentage of the float for ACRX is very high at 16.9%. The bears have also been increasing their bets from the last reporting period by 35.5%, or by about 836,000 shares. If that breakout triggers soon

• [By Garrett Cook]

  Healthcare shares fell 0.13 percent on Friday. Top losers in the sector included AcelRx Pharmaceuticals (NASDAQ: ACRX), down 18 percent, and Repligen (NASDAQ: RGEN), off 3.7 percent.

10 Best Healthcare Equipment Stocks To Invest In 2014: Banco Bilbao Vizcaya Argentaria S.A. (BBVA)

Banco Bilbao Vizcaya Argentaria, S.A. (BBVA) is a diversified international financial group, with strengths in the traditional banking businesses of retail banking, asset management, private banking and wholesale banking. The Company also has investments in some of Spain�� companies. During the year ended December 31, 2009, BBVA focused its operations on six major business areas: Spain and Portugal, Wholesale Banking and Asset Management, Mexico, The United States, South America and Corporate Activities. On August 21, 2009, through its subsidiary BBVA Compass, BBVA acquired certain assets of Guaranty from the United States Federal Deposit Insurance Corporation (the FDIC).

Spain and Portugal

The Spain and Portugal business area focuses on providing banking services and consumer finance to private individuals, enterprises and institutions in Spain and Portugal. The main business units included in the Spain and Portugal area Spanish Retail Network, which manages individual customers, high net-worth individuals (private banking) and small companies and retailers in the Spanish market; Corporate and Business Banking, which manages business with small and medium enterprises (SMEs), large companies, institutions and developers in the Spanish market, and Other units, which includes consumer finance, that manages renting and leasing business, credit to individual and to enterprises for consumer products and Internet banking; European Insurance that manages the insurance business in Spain and Portugal, and BBVA Portugal, that manages the banking business in Portugal. The Spanish Retail Network unit services the financial and non-financial needs of households, professional practices, retailers and small businesses. The Corporate and Business Banking unit offers a range of services and products to SMEs, large companies, institutions and developers with specialized branch networks for each segment.

The Company�� European Insurance unit�� activities are conducted through! various insurance companies that provide direct insurance, reinsurance and insurance brokering services in Spain and Portugal and market products for different types of customers (private individuals, SMEs, retailers, professional service firms and providers and self-employed individuals) through this unit�� branch offices. BBVA Portugal manages its banking business in Portugal.

Wholesale Banking and Asset Management

The Wholesale Banking and Asset Management area focuses on providing services to large international companies and investment banking, capital markets and treasury management services to clients. The business units included in the Wholesale Banking and Asset Management area are Corporate and Investment Banking, which coordinates origination, distribution and management of a complete catalogue of corporate and investment banking products (corporate finance, structured finance, syndicated loans and debt capital markets) and provides global trade finance and global transaction services with coverage of large corporate customers specialized by sector (industry bankers); Global Markets, which handles the origination, structuring, distribution and risk management of market products, which are placed through its trading rooms in Europe, Asia and the Americas; Asset Management, which designs and manages the products that are marketed through its different branch networks including traditional asset management, alternative asset management and Valanza (its private equity unit); Industrial and Other Holdings, which helps to diversify the area�� businesses with the aim of creating medium and long-term value through active management of a portfolio of industrial holdings and other Spanish and international projects, and Asia.

During the year ended December 31, 2009, it launched two products: BBVA Bonos Cash (BBVA Cash Bonds), a money market fund for retail customers, and BBVA Bonos Largo Plazo Gobiernos II (BBVA Long-Term Government Bonds), a public-debt fu! nd. In ad! dition it launched through this unit additional fixed-income long-term funds, including BBVA Bonos Corporativos 2011 and BBVA Bonos 2014, which were sold to HNWI customers.

Mexico

The business units included in the Mexico area are Retail and Corporate banking and Pensions and Insurance. BBVA Bancomer launched six new mortgage products for lending to home buyers in 2009. These products included: loans for home improvements, remodeling or additions to homes and financial discount which provides liquidity to construction companies. In Mexico, it operates its pensions business through Afore Bancomer, its insurance business through Seguros Bancomer, its annuities business through Pensiones Bancomer and its health insurance business through Preventis.

The United States

The business units included in the United States area are BBVA Compass and Other units: BBVA Puerto Rico and Bancomer Transfers Services (BTS). During 2009 this unit marketed and sold several new products, The ClearPoints credit card, Business Build-to-order Checking, Compass for your Cause and Money Market Sweep.

South America

The South America business area includes its banking, insurance and pension businesses in South America. The business units included in the South America business area are Retail and Corporate Banking, which includes banks in Argentina, Chile, Colombia, Panama, Paraguay, Peru, Uruguay and Venezuela; Pension businesses, which includes pensions businesses in Argentina, Bolivia, Chile, Colombia, Ecuador and Peru and Dominican Republic, and Insurance businesses, which includes insurance businesses in Argentina, Chile, Colombia, Dominican Republic and Venezuela.

Corporate Activities

The Corporate Activities area handles its general management functions. These mainly consist of structural positions for interest rates associated with the euro balance sheet and exchange rates, together with liquidity management and shareholde! rs��fun! ds.

Advisors' Opinion:

• [By John Udovich]
  A.F.P Provida SA. A Chile-based company�involved in the management of private pension funds, A.F.P Provida SA�� activities include the investment and collection of its clients��contributions, the management of individual capitalization accounts and the provision of life and disability benefits, payments of funeral expenses and senior retirement pensions. A.F.P Provida SA also has operations through its subsidiaries in Peru, Ecuador and Mexico. Under former dictator Pinochet,�Chile privatized its otherwise bankrupted social security program�and mandates its citizens to invest a certain portion of their wages with government-endorsed asset management firms like A.F.P Provida SA. Right now, A.F.P Provida SA has a trailing P/E of 6.33 along with a forward dividend of $10.89 for a 12% dividend yield, but there is also a big catch. Back in February, it was reported that Metlife Inc (NYSE: MET) would acquire the firm from Banco Bilbao Vizcaya Argentaria SA (NYSE: BBVA) in a deal valued at about $2 billion in order to add fee income in Latin America���meaning that juicy dividend is no longer a sure bet for investors. On Monday, small cap A.F.P Provida SA rose 0.28% to $90.80 (PVD has 52 week trading range of $82.60 to $112.79 a share) for a market cap of $2.01 billion plus the stock is down 9.1% since the start of the year, up 2.3% over the past year and up 205.7% over the past five years.

• [By Jim Woods]

  If you’re looking for an income-producing dividend stock to fill the void, consider the classic pure plays AT&T (T) and Verizon (VZ).

  Banco Bilbao Vizcaya Argentaria (BBVA)
  

  When it comes to suspending dividends, the Europeans don�� want to be left out. In October, Spain�� biggest financial institution, Banco Bilbao Vizcaya Argentaria (BBVA), cut its annual dividend by putting a cap on payouts for 2014 (and going forward) to 40% of profits.

• [By fedezaldua]

  On the capitalization side, Santander has gotten significantly better, and I would expect the bank to show a Basel 2 tier 1 capital ratio of 12% by the end of 2014, which is around what most analysts expect for its closest peer, Banco Bilbao Viscaya Argentaria (BBVA) ��most commonly known as BBVA.

• [By Dan Burrows]

  Between the almost gluttonous dividend yield of 7.4% and Blackstone’s solid track record of essentially printing money, shares are sure to return to their total-return winning ways. Even with the recent underperformance, BX stock has a 1-year total return of 58%.

  Banco Bilbao Vizcaya Argentaria (BBVA)

  Dividend Yield: 7.4%
  1-Year Total Return: 47%

10 Best Healthcare Equipment Stocks To Invest In 2014: SABMiller PLC (SBMRY)

SABMiller plc, incorporated on March 17, 1998, is a holding company, which has brewing and beverage interests across six continents. The Company together with its subsidiaries is engaged in the manufacture, distribution and sale of beverages. The Company is a brewer with more than 200 beer brands. The Company�� portfolio of brands includes international beers, such as Pilsner Urquell, Peroni Nastro Azzurro, Miller Genuine Draft and Grolsch, as well as local brands, such as Aguila, Castle, Miller Lite, Snow, Tyskie and Victoria Bitter. It is a bottler for the Coca-Cola Company in Africa and Central America. It operates in Latin America, Europe, North America, Africa, Asia Pacific, and South Africa.

Latin America

The Company�� primary brewing and beverage operations cover six countries across South and Central America (Colombia, Ecuador, El Salvador, Honduras, Panama and Peru). The Company is brewer in Argentina, and it exports to Bolivia, Chile and Paraguay. It bottles soft drinks for The Coca-Cola Company in El Salvador and Honduras, and for Pepsico International in Panama.

Europe

The Company�� primary brewing operations cover eight countries: the Czech Republic, Hungary, Italy, Poland, Romania, Slovakia, Spain (Canary Islands) and the Netherlands. A further 16 countries, including Russia, Turkey and the Ukraine are covered in a strategic alliance with Anadolu Efes through brewing, soft drinks or export operations. The Company exports volumes to a further seven European markets, of which the largest are the United Kingdom and Germany.

North America

The Company�� North America segment includes its 58% owned MillerCoors and 100% of Miller Brewing International and the its North American holding companies. The Company�� wholly owned Miller Brewing International business is based in Milwaukee, the United States and exports its brands to Canada and Mexico and throughout the Americas.

Africa

The Compa! ny�� brewing and beverage operations in Africa cover 15 countries. A further 21 are covered through a strategic alliance with the Castel group and it also has an associated undertaking in Zimbabwe. The Company bottles soft drinks for The Coca-Cola Company in 20 of its African markets (in alliance with Castel in 14 of these markets).

Asia Pacific

The Company�� partners with China Resources Enterprise, Limited in China. The Company is engaged in brewing business in India. The Company has operation in Vietnam and it exports to various markets, including South Korea and Singapore.

South Africa

The Company�� South African Breweries (Pty) Ltd (SAB) is South Africa�� producer and distributor of lager and soft drinks. It also exports brands for distribution across Namibia. Its soft drinks division is bottler of products for The Coca-Cola Company. The Company has hotel and gaming interests through its associate, Tsogo Sun Holdings Ltd, a hotel and gaming group in South Africa.

Advisors' Opinion:

• [By Barry James]

  LONDON -- In its final results for the year to March 31, SABMiller (LSE: SAB  ) (NASDAQOTH: SBMRY  ) , the global beverage-brewer and bottler with more than 200 beer brands and Coca-Cola bottling operations, saw group revenue increase by 10% to $34.5 billion and EBITA rise 14% to $6.4 billion, while pre-tax profit fell 16% to $4.7 billion.

• [By Rich Duprey]

  Recently, Anheuser-Busch InBev (NYSE: BUD  ) introduced in the U.S. its Stella Artois Cidre brand of cider as a means of siphoning off wine drinkers but also trying to steal some of Boston Beer's thunder. According to GuestMetrics, hard cider sales soared 70% in the first quarter, and it was largely on the back of Angry Orchard. Notably, MillerCoors, the joint venture between SABMiller (NASDAQOTH: SBMRY  ) and Molson Coors (NYSE: TAP  ) , also acquired cider maker Crispin last year.

• [By John Mitchell]

  "No one wants to annoy the consumer," Bill Bean, director of trade�insight at SAB Miller (NASDAQOTH: SBMRY  ) , told the New York Times.�"However, there are many annoying ads that sell products, and it's very difficult to tell what annoys one consumer and what pleases another."�